Neurotech progresses ASD trial, inks deal with contract research organisation by Martin Lane April 10, 2024July 16, 2024 The 54th and final patient has completed their last visit as part of Neurotech’s Phase II/III […]
Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024July 16, 2024
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023April 30, 2024
Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health by Martin Lane November 14, 2023April 30, 2024
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Neurotech reports positive results from latest trial of cannabinoid drug candidate NTI164 by Martin Lane October 6, 2023April 30, 2024
Company news: Vantage Hemp; Neurotech International; MediPharm Labs/Beacon Medical; Cann Group by Martin Lane September 28, 2023April 30, 2024
